Search alternatives:
larger decrease » marked decrease (Expand Search)
small decrease » small increased (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
sand decrease » mean decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
small decrease » small increased (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
sand decrease » mean decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
21
Biases in larger populations.
Published 2025“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
-
22
-
23
-
24
-
25
-
26
Grid division diagram.
Published 2025“…The decrease is the largest, and sand particles are easy to deposit here in large quantities. …”
-
27
Model calculation diagram.
Published 2025“…The decrease is the largest, and sand particles are easy to deposit here in large quantities. …”
-
28
Grid independence verification.
Published 2025“…The decrease is the largest, and sand particles are easy to deposit here in large quantities. …”
-
29
-
30
-
31
Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
Published 2025Subjects: -
32
Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
Published 2025Subjects: -
33
Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
Published 2025Subjects: -
34
-
35
-
36
Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx
Published 2025“…The reduction in SSC may influence chlorophyll-a (Chl-a) concentrations in water, thereby further affecting the aquatic ecological environment. …”
-
37
-
38
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
39
-
40